Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study.

Emanuel JE, Lopez OL, Houck PR, Becker JT, Weamer EA, Demichele-Sweet MA, Kuller L, Sweet RA.

Am J Geriatr Psychiatry. 2011 Feb;19(2):160-8. doi: 10.1097/JGP.0b013e3181e446c8.

2.

Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.

Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Jul;22(7):698-707. doi: 10.1016/j.jagp.2012.10.028. Epub 2013 Mar 15.

PMID:
23672944
3.

Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.

Koppel J, Goldberg TE, Gordon ML, Huey E, Davies P, Keehlisen L, Huet S, Christen E, Greenwald BS.

Am J Geriatr Psychiatry. 2012 Nov;20(11):994-1000. doi: 10.1097/JGP.0b013e3182358921.

PMID:
22048323
4.

EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.

Lopez OL, Brenner RP, Becker JT, Ulrich RF, Boller F, DeKosky ST.

Neurology. 1997 Jun;48(6):1521-5.

PMID:
9191759
5.

Quantitative electroencephalographic correlates of psychosis in Alzheimer disease.

Edwards-Lee T, Cook I, Fairbanks L, Leuchter A, Cummings JL.

Neuropsychiatry Neuropsychol Behav Neurol. 2000 Jul;13(3):163-70.

PMID:
10910086
6.

The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.

Weamer EA, Emanuel JE, Varon D, Miyahara S, Wilkosz PA, Lopez OL, Dekosky ST, Sweet RA.

Int Psychogeriatr. 2009 Feb;21(1):78-85. doi: 10.1017/S1041610208007734. Epub 2008 Sep 25.

7.

Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.

Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, Carlson MC, Yasar S, Dekosky S, Burke GL.

J Stroke Cerebrovasc Dis. 2012 Aug;21(6):436-44. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002. Epub 2011 Jan 14.

8.

Alzheimer disease subjects with psychosis have increased schizotypal symptoms before dementia onset.

Eror EA, Lopez OL, Dekosky ST, Sweet RA.

Biol Psychiatry. 2005 Aug 15;58(4):325-30.

PMID:
15978552
9.

Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes.

Wilkosz PA, Miyahara S, Lopez OL, Dekosky ST, Sweet RA.

Am J Geriatr Psychiatry. 2006 Apr;14(4):352-60.

PMID:
16582044
10.

Trajectories of cognitive decline in Alzheimer's disease.

Wilkosz PA, Seltman HJ, Devlin B, Weamer EA, Lopez OL, DeKosky ST, Sweet RA.

Int Psychogeriatr. 2010 Mar;22(2):281-90. doi: 10.1017/S1041610209991001. Epub 2009 Sep 28.

11.

Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.

Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB.

Arch Neurol. 2012 Sep;69(9):1170-5. doi: 10.1001/archneurol.2012.1117.

12.

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1999 Oct;56(10):1266-72.

PMID:
10520944
13.

Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.

Balasubramanian AB, Kawas CH, Peltz CB, Brookmeyer R, Corrada MM.

Neurology. 2012 Aug 28;79(9):915-21. doi: 10.1212/WNL.0b013e318266fc77. Epub 2012 Aug 15.

14.

The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG.

Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95. doi: 10.1016/j.jagp.2013.01.006. Epub 2013 Feb 6.

15.

Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality.

Vilalta-Franch J, López-Pousa S, Calvó-Perxas L, Garre-Olmo J.

Am J Geriatr Psychiatry. 2013 Nov;21(11):1135-43. doi: 10.1016/j.jagp.2013.01.051. Epub 2013 Feb 6.

PMID:
23567368
16.

Non-cognitive symptoms in mild cognitive impairment subjects.

Lopez OL, Becker JT, Sweet RA.

Neurocase. 2005 Feb;11(1):65-71.

PMID:
15804926
17.

Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.

Yoon JH, Kim M, Moon SY, Yong SW, Hong JM.

J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.

PMID:
26076880
18.

The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.

Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L.

Arch Neurol. 2000 Jun;57(6):839-44.

PMID:
10867781
19.

Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Morris JC.

Arch Neurol. 2012 Jun;69(6):700-8. doi: 10.1001/archneurol.2011.3152.

20.

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.

van Rossum IA, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P.

J Alzheimers Dis. 2012;29(2):319-27. doi: 10.3233/JAD-2011-111694.

PMID:
22233766

Supplemental Content

Support Center